CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Legal Officer sold 551 shares at $73.57 ($40,539)
- 4 Planned sale Chief Legal Officer sold 114 shares at $76.99 ($8,777)
- 4 Planned sale President sold 318 shares at $76.99 ($24,483)
- 4 Planned sale Chief Financial Officer sold 162 shares at $78.03 ($12,640)
- 4 Planned sale Chief Legal Officer sold 162 shares at $78.03 ($12,640)
- 4 Planned sale President sold 300 shares at $78.03 ($23,408)
- 4 Planned sale Chief Financial Officer sold 1,321 shares at $79.39 ($104,881)
- 4 Planned sale Chief Legal Officer sold 1,319 shares at $79.39 ($104,722)
- 4 Planned sale President sold 254 shares at $84.10 ($21,363)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Director sold 15,000 shares at an average $119.96 ($1,799,443)
- 4 Planned sale Director sold 15,000 shares at an average $117.80 ($1,766,972)
- 4 Planned sale Director sold 15,000 shares at an average $122.84 ($1,842,651)
- 4 Planned sale President sold 15,000 shares at $121.12 ($1,816,800)
- 4 Planned sale Director sold 15,000 shares at an average $117.08 ($1,756,177)
- 4 Planned sale Chief Financial Officer sold 689 shares at $118.24 ($81,465)
- 4 Planned sale Director sold 15,000 shares at an average $127.22 ($1,908,293)
- 4 Planned sale Director sold 15,000 shares at an average $133.57 ($2,003,561)
Page 7 of 54 · 1,067 filings